March 2, 2022
MiGenTra Announces Formation of International Advisory Board
MiGenTra, headquartered in Berlin, Germany and MiGenTra Egypt, located with its ‘Facility of the Future’ in Cairo, Egypt, have announced…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
March 2, 2022
Accure Therapeutics Licences Neuroprotective Drug Candidate to Ophthalmology Company Oculis
Oculis and Accure Therapeutics have announced a licensing agreement granting Oculis exclusive global rights to develop and commercialize ACT-01, a…
March 2, 2022
Holographyx Announces U.S. and European Patent for Anti-Counterfeiting System for Blister-Packs
Holographyx has been granted a U.S. patent for its Holo-Blister product along with a European Patent for the development of…
March 2, 2022
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, has…
March 1, 2022
AbbVie Acquires V-Bio Ventures’s Portfolio Company Syndesi Therapeutics
V-Bio Ventures has announced the completion the acquisition of its portfolio company Syndesi Therapeutics SA by AbbVie (NYSE: ABBV), which…
March 1, 2022
Thermo Fisher Scientific Extends Collaboration with Symphogen to Advance Biopharmaceutical Discovery and Development
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier,…
March 1, 2022
Kingdom of Bahrain OKs Valneva’s Inactivated COVID-19 Vaccine
National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain has granted emergency use authorization for Valneva’s inactivated, adjuvanted COVID-19…
February 28, 2022
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investmen
Heidelberg Pharma and Huadong Medicine have entered into a strategic partnership with the signing of an exclusive licensing agreement as…
February 28, 2022
Kapruvia Receives Positive CHMP Opinion for the Treatment of Moderate-to-Severe Pruritus in Hemodialysis Patients
Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, have announced that the European Medicines Agency’s (EMA) CHMP has recommended…
February 28, 2022
Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat in Patients with Alzheimer’s Disease
Vivoryon Therapeutics a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group have announced that…